survivin inhibitors (Clinical Data)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namesurvivin inhibitors (Clinical Data)
Drug Alias Namesurvivin inhibitors (Avalon)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBaculoviral IAP repeat-containing protein 5 inhibitors
TargetsBaculoviral IAP repeat-containing protein 5
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAvalon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesClinical Data IncAvalon Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A